^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

chlorogenic acid

Associations
Trials
Company:
Jiuzhang Biotech
Drug class:
Immunomodulator
Related drugs:
Associations
Trials
5d
Chlorogenic acid-ZnO nanocomposite derived from Hydrocotyle javanica Thunb. activates ferroptosis-regulated cell death axis in breast cancer cells. (PubMed, Nanomedicine)
Additionally, CGA-ZnO downregulated the expression of phospho-NRF2, GPx, xCT and elevated ferritin, DMT1, cleaved CASPASE 3 to activate ferroptosis-regulated cell death axis. Furthermore, rescue assay confirmed the mechanism of CGA-ZnO in efficient killing of breast cancer cells.
Journal
|
CASP3 (Caspase 3) • CCNA2 (Cyclin A2) • CDK2 (Cyclin-dependent kinase 2) • CDKN1A (Cyclin-dependent kinase inhibitor 1A) • CAT (Catalase) • DMRT1 (Doublesex And Mab-3 Related Transcription Factor 1)
|
chlorogenic acid
19d
Exploiting autophagy-targeting natural compounds for potential antimicrobial actions. (PubMed, Autophagy)
This review discusses the current knowledge of natural products in terms of their antimicrobial actions through autophagy regulation, particularly the roles of distinct natural product classes, such as polyphenols, alkaloids, terpenoids, quinones, peptides, and macrolides in modulating autophagy for potentially contributing to control various infectious diseases. Exploring the intricate molecular interplay between natural products and autophagy in limiting infections may provide valuable insights that could inform the development of innovative host-directed antimicrobial treatments based on autophagy regulation.Abbreviations: 3-MA: 3-methyladenine; AM: alveolar macrophages; AMP: antimicrobial peptides; AMPK: 5' adenosine monophosphate-activated protein kinase; ARDS: acute respiratory distress syndrome; ART: artemisinin; ASFV: African swine fever virus; ATG: autophagy related; AZM: azithromycin; BafA1: bafilomycin A1; BECN1: beclin 1; BMDM: bone marrow-derived macrophage; BNIP3: BCL2 interacting protein 3; BNIP3L: BCL2 interacting protein 3 like; CALCOCO2/NDP52: calcium binding and coiled-coil domain 2; CAMKK2: calcium/calmodulin-dependent protein kinase kinase 2; CBD: cannabidiol; CF: cystic fibrosis; CGA: chlorogenic acid; CGAS: cyclic GMP-AMP synthase; CHUK/IKKα: component of inhibitor of nuclear factor kappa B kinase complex; CLP: cecal ligation and puncture; CLR: clarithromycin; CMA: chaperone-mediated autophagy; CoV: coronavirus; DHT: dihydrotanshinone I; EGCG: epigallocatechin-3-gallate; EIF2A: eukaryotic translation initiation factor 2A; EIF2AK2: eukaryotic translation initiation factor 2 alpha kinase 2; ESKAPE: Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp.; ESRRA: estrogen related receptor alpha; FOXO1: forkhead box O1; FUNDC1: FUN14 domain containing 1; HBV: hepatitis B virus; HCV: hepatitis C virus; HDT: host-directed therapy; HIV: human immunodeficiency virus; HMGB1: high mobility group box 1; HSV: herpes simplex virus; IAV: influenza A virus; ICT: isocryptotanshinone; IFN: interferon; IKBKB/IKKβ: inhibitor of nuclear factor kappa B kinase subunit beta; IL: interleukin; INH: isoniazid; IRF3: IFN regulatory factor 3; KEAP1: kelch like ECH associated protein 1; LAMP: lysosomal associated membrane protein; LAP: LC3-associated phagocytosis; LPS: lipopolysaccharide; MAP1LC3/LC3: microtubule associated protein 1 light chain 3; MAPK: mitogen-activated protein kinase; MDM: monocyte-derived macrophage; MDR: multidrug-resistant; MON: monotropein; Mtb: Mycobacterium tuberculosis; MTOR: mechanistic target of rapamycin kinase; mtROS: mitochondrial ROS; NET: neutrophil extracellular trap; NFE2L2/Nrf2: NFE2 like bZIP transcription factor 2; NFKB/NF-κB: nuclear factor kappa B; NLRP3: NLR family pyrin domain containing 3; NLRX1: NLR family member X1; NOTCH1: notch receptor 1; NTM: nontuberculous mycobacteria; OMS: ohmyungsamycin; PAK1: p21 (RAC1) activated kinase 1; PINK1: PTEN induced kinase 1; PKM/PKM2: pyruvate kinase M1/2; PLD: phospholipase D; PM: peritoneal macrophage; PPM1A: protein phosphatase, Mg2+/Mn2+ dependent 1A; PRKN/parkin: parkin RBR E3 ubiquitin protein ligase; PtdIns3K: phosphatidylinositol 3-kinase; PtdIns3P: phosphatidylinositol-3-phosphate; PTEN: phosphatase and tensin homolog; RB1CC1/FIP200: RB1 inducible coiled-coil 1; RELA/p65: RELA proto-oncogene, NF-kB subunit; RIF: rifampicin; ROS: reactive oxygen species; RSV: resveratrol; RUBCN/rubicon: rubicon autophagy regulator; SAR: selective autophagy receptor; SIRT: sirtuin; STING1: stimulator of interferon response cGAMP interactor 1; STX17: syntaxin 17; Tat: trans-activator of transcription; TB: tuberculosis; TBK1: TANK binding kinase 1; TFEB: transcription factor EB; TLR: toll like receptor; TNA: tanshinone IIA; TNF: tumor necrosis factor; UA: ursolic acid; ULK1/Atg1: unc-51 like autophagy activating kinase 1; UPR: unfolded protein response; UVRAG: UV radiation resistance associated; VAMP8: vesicle associated membrane protein 8; VDR: vitamin D receptor; WIPI2: WD repeat domain, phosphoinositide interacting 2; ZFYVE1/DFCP1: zinc finger FYVE-type containing 1; ZIKV: Zika virus.
Review • Journal
|
PTEN (Phosphatase and tensin homolog) • BCL2 (B-cell CLL/lymphoma 2) • RB1 (RB Transcriptional Corepressor 1) • NOTCH1 (Notch 1) • KEAP1 (Kelch Like ECH Associated Protein 1) • mTOR (Mechanistic target of rapamycin kinase) • TNFA (Tumor Necrosis Factor-Alpha) • STING (stimulator of interferon response cGAMP interactor 1) • RAC1 (Rac Family Small GTPase 1) • HMGB1 (High Mobility Group Box 1) • BNIP3L (BCL2 Interacting Protein 3 Like) • ALPK2 (Alpha Kinase 2) • BNIP3 (BCL2 Interacting Protein 3) • CDKN1A (Cyclin-dependent kinase inhibitor 1A) • CGAS (Cyclic GMP-AMP Synthase) • EIF2A (Eukaryotic Translation Initiation Factor 2A) • MAP1LC3B (Microtubule Associated Protein 1 Light Chain 3 Beta) • NLRP3 (NLR Family Pyrin Domain Containing 3) • PAK1 (p21 (RAC1) activated kinase 1) • TFEB (Transcription Factor EB 2) • AMPK (Protein Kinase AMP-Activated Catalytic Subunit Alpha 1) • BECN1 (Beclin 1) • EIF2S1 (Eukaryotic Translation Initiation Factor 2 Subunit Alpha) • ESRRA (Estrogen Related Receptor Alpha) • PKM (Pyruvate Kinase M1/2) • PPM1A (Protein Phosphatase Mg2+/Mn2+ Dependent 1A) • RB1CC1 (RB1 Inducible Coiled-Coil 1) • RELA (RELA Proto-Oncogene) • UBR5 (Ubiquitin Protein Ligase E3 Component N-Recognin 5)
|
sirolimus • chlorogenic acid • rifampicin
26d
Identification of Polo-like kinase-1 (PLK-1) inhibitors from Centella asiatica (Gotu Kola) using UHPLC and in-silico approaches. (PubMed, Nat Prod Res)
The 90% ethanol-aqueous extract of C. asiatica whole plant, which was prepared at room temperature, contained ten bioactive compounds including rutin, quercetin, kaempferol, chlorogenic acid, fisetin, apigenin, asiatic acid, fumaric acid, betulinic acid and ursolic acid identified by UHPLC method. As our findings, rutin was identified as a promising PLK-1 inhibitor that exhibited significant docking score -13.07 and high stability within the binding pockets of PLK-1 protein as compared to control drug onvansertib. Furthermore, experimental validation is urgently needed for future translational research to develop rutin as potent PLK-1 inhibitor for treating cancer.
Journal
|
PLK1 (Polo Like Kinase 1)
|
onvansertib (PCM-075) • chlorogenic acid
26d
Identification of anticancer and cardioprotective quality markers in Chuanxiong Rhizoma using a bioassay driven effect-constituent index approach. (PubMed, J Pharm Biomed Anal)
HPLC profiling of 12 commercial batches identified ten common constituents: tetramethylpyrazine, chlorogenic acid, ferulic acid, senkyunolide I, senkyunolide H, 6″-feruloylspinosin, senkyunolide A, n-butylbenzene, ligustilide, and butenylbenzene. Molecular docking indicated that bioactive constituents may modulate ferroptosis via interactions with SLC7A11 and FSP1. The integrated ECI framework offers an efficacy-driven quality control approach for Chuanxiong Rhizoma and supports its dual application to enhance antitumor activity while mitigating trastuzumab-induced cardiotoxicity.
Journal
|
HER-2 (Human epidermal growth factor receptor 2) • SLC7A11 (Solute Carrier Family 7 Member 11) • AIFM2 (Apoptosis Inducing Factor Mitochondria Associated 2)
|
HER-2 positive
|
Herceptin (trastuzumab) • chlorogenic acid
27d
Anisotropic Excipient-Free Buccal Wafer Engineered by Directional Freezing for Structure-Guided Neuro-Immune Therapy against Chemotherapy-Induced Emesis. (PubMed, Acta Biomater)
In a cisplatin-induced rat emesis model, IJ-ODW reduced kaolin intake by 18.3% (p 10 h)...STATEMENT OF SIGNIFICANCE: This study reports the rational design of an anisotropic, excipient-free buccal wafer, which overcomes the fundamental "speed-stability paradox" in mucosal delivery through its engineered bilayered architecture. By integrating ultrafast adhesion with sustained, polarity-selective release and active neuro-immune modulation, this material platform provides a scalable and dysphagia-tailored therapeutic strategy, advancing the design of multifunctional biomaterials for complex clinical needs.
Journal
|
IL6 (Interleukin 6) • DRD2 (Dopamine Receptor D2)
|
cisplatin • dexamethasone • chlorogenic acid • ondansetron
1m
Chlorogenic acid (CGA) exerts antidepressant-like effects by regulating SIRT1/FoxO3a/PINK1/Parkin pathway in LPS-induced depressive mice. (PubMed, Cell Signal)
A growing focus in nutritional psychiatry is examining dietary interventions as a therapeutic strategy for depression. The antidepressant-like effects of CGA were suppressed upon SIRT1 antagonism with EX527. This study suggests that CGA may serve as a potential therapeutic agent for depression.
Preclinical • Journal
|
PTEN (Phosphatase and tensin homolog) • IL6 (Interleukin 6) • FOXO3 (Forkhead box O3) • IL1B (Interleukin 1, beta) • SIRT1 (Sirtuin 1)
|
selisistat (SEN-196) • chlorogenic acid
1m
Rewiring Metal-Dependent Cell Death to Unlock Immunotherapy in Colorectal Cancer. (PubMed, Nano Lett)
Decitabine restores gasdermin E expression to couple oxidative stress with caspase-3-mediated pyroptosis, while chlorogenic acid repolarizes tumor-associated macrophages toward a pro-inflammatory phenotype. This coordinated multimodal cell-death cascade establishes a self-amplifying immunogenic circuit that suppresses tumor growth, sensitizes CRC to ICB, and elicits systemic antitumor immunity.
Journal • PD(L)-1 Biomarker • IO biomarker
|
CASP3 (Caspase 3) • GSDME (Gasdermin E)
|
decitabine • chlorogenic acid
2ms
LC/MS-Based Phytochemical Profiling and Immunomodulatory Evaluation of Three Medicinal Plants With Anticancer and Antibacterial Activities. (PubMed, Chem Biodivers)
aureum was enriched in ferulic acid, rutin, chlorogenic acid, and p-coumaric acid, whereas A. mexicana contained veratric acid, luteolin, and apigenin...These findings highlight a clear relationship between phytochemical composition and biological activity, indicating that these medicinal plants may serve as promising sources of multitarget phytotherapeutic agents. Further in vivo studies and bioactive compound isolation are required to validate their therapeutic potential.
Journal • IO biomarker
|
BCL2 (B-cell CLL/lymphoma 2) • IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • BAX (BCL2-associated X protein)
|
chlorogenic acid
2ms
Brewed Coffee and Its Components Act Through Orphan Nuclear Receptor 4A1 (NR4A1). (PubMed, Nutrients)
Brewed coffee and several polyphenolics, including caffeic acid, ferulic acid, chlorogenic acid, p-coumaric acid, several cinnamic acid derivatives, kahweol, and cafestrol, bound NR4A1 in binding assays, and most Kd values were <10 µM... The results of this study demonstrate that brewed coffee and its major polyphenolics and polyhydroxy constituents are NR4A1 ligands and that NR4A1 may play an important role in the health-protective effects of coffee. These results, coupled with recent studies, indicate that NR4A1 and its ligands may play an important role in diet and health.
Journal
|
NR4A1 (Nuclear Receptor Subfamily 4 Group A Member 1)
|
chlorogenic acid
2ms
Preliminary Anti-Melanoma Activity of a Chlorogenic Acid-Based PROTAC Targeting MDM4, a Candidate Protein Identified by Proteomics. (PubMed, Foods)
These compounds incorporated the natural product CGA as the target-binding ligand, conjugated to pomalidomide (an E3 ligase-recruiting moiety) via various synthetic linkers. This study successfully applied an effective strategy for target identification and medication discovery of natural compounds. In addition, CGA-PROTAC A7 was synthesized in one step with an overall yield of 45.96%, providing a feasible route for synthesis and establishing a basis for the combination of natural product polyphenols with PROTAC technology.
Journal
|
MDM4 (The mouse double minute 4) • CDKN1A (Cyclin-dependent kinase inhibitor 1A)
|
pomalidomide • chlorogenic acid
2ms
Cynara cardunculus subsp. cardunculus (Wild Artichoke) Extract: Antimicrobial Activity and Cytotoxicity, Apoptosis Induction, and Chemosensitization in Colon Cancer Cells. (PubMed, Biology (Basel))
Additionally, CCE demonstrated synergistic effects with 5-FU (combination index < 0.8). This evidence suggests that CCE exhibits selective antitumor activity and chemosensitizing properties, supporting its possible development as an adjunctive agent in CRC therapy.
Journal
|
CASP3 (Caspase 3)
|
5-fluorouracil • chlorogenic acid
2ms
Pharmacokinetic-pharmacodynamic modeling of Laportea bulbifera extract in adjuvant-induced arthritis rats via joint cavity microdialysis. (PubMed, J Pharm Biomed Anal)
Based on half maximal inhibitory concentration, the inhibitory potency of the five components against the four biomarkers was ranked as follows: kaempferol-3-O-rutinoside > neochlorogenic acid > rutin > chlorogenic acid > cryptochlorogenic acid. The effect compartment model revealed a linear relationship between RF and multiple components, underscoring RF's potential role as a key therapeutic target in the joint cavity. This study represents the first systematic elucidation of the local PK-PD characteristics of LBE, providing a scientific basis for developing this Miao medicinal herb and its clinical application in rheumatoid arthritis.
PK/PD data • Preclinical • Journal
|
IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • IL1B (Interleukin 1, beta)
|
chlorogenic acid